Skip to content
Screener

Septerna, Inc. SEPN Total Liabilities & Equity

Total Liabilities & Equity at other companies

Amgen logo
AmgenAMGN
$95.64B+8.8%
Tectonic Therapeutics logo
Tectonic TherapeuticsTECX
$246.58M-21.7%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$443.28M+8.9%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$458.98M+60.8%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$535.54M-9.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$1.29B+81.1%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759
Line itemMarch 31, 2026December 31, 2025
Stockholders' equity:
Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value per share, 500,000,000 shares authorized at March 31, 2026 and December 31, 2025; 44,916,572 and 44,806,272 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively; 75,247 and 131,224 shares subject to repurchase as of March 31, 2026 and December 31, 2025, respectively4545
Additional paid-in capital554,872548,517
Accumulated other comprehensive (loss) income(569)617
Accumulated deficit(175,890)(167,253)
Total stockholders' equity378,458381,926
Total liabilities and stockholders' equity$569,688$596,187

Item 1. Condensed Financial Statements.

FAQ

What is Septerna, Inc.'s total liabilities & equity?
Septerna, Inc. (SEPN) reported total liabilities & equity of $569.69M in Q1 2026.
How has Septerna, Inc.'s total liabilities & equity changed year-over-year?
Septerna, Inc.'s total liabilities & equity increased by 31.3% year-over-year, from $434.02M to $569.69M.
What is the long-term trend for Septerna, Inc.'s total liabilities & equity?
Over 2 years (2023 to 2025), Septerna, Inc.'s total liabilities & equity has grown at a 113.4% compound annual growth rate (CAGR), from $130.87M to $596.19M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Septerna, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude